换一批
换一批
作者：
John G,Hanly [1]
;
Aidan G,O'Keeffe [2]
;
Li,Su [3]
;
Murray B,Urowitz [4]
;
Juanita,Romero-Diaz [5]
;
Caroline,Gordon [6]
;
Sang-Cheol,Bae [7]
;
Sasha,Bernatsky [8]
;
Ann E,Clarke [9]
;
Daniel J,Wallace [10]
;
Joan T,Merrill [11]
;
David A,Isenberg [12]
;
Anisur,Rahman [12]
;
Ellen M,Ginzler [13]
;
Paul,Fortin [14]
;
Dafna D,Gladman [4]
;
Jorge,Sanchez-Guerrero [4]
;
Michelle,Petri [15]
;
Ian N,Bruce [16]
;
Mary Anne,Dooley [17]
;
Rosalind,Ramsey-Goldman [18]
;
Cynthia,Aranow [19]
;
Graciela S,Alarcón [20]
;
Barri J,Fessler [20]
;
Kristjan,Steinsson [21]
;
Ola,Nived [22]
;
Gunnar K,Sturfelt [22]
;
Susan,Manzi [23]
;
Munther A,Khamashta [24]
;
Ronald F,van Vollenhoven [25]
;
Asad A,Zoma [26]
;
Manuel,Ramos-Casals [27]
;
Guillermo,Ruiz-Irastorza [28]
;
S Sam,Lim [29]
;
Thomas,Stoll [30]
;
Murat,Inanc [31]
;
Kenneth C,Kalunian [32]
;
Diane L,Kamen [33]
;
Peter,Maddison [34]
;
Christine A,Peschken [35]
;
Soren,Jacobsen [36]
;
Anca,Askanase [37]
;
Chris,Theriault [38]
;
Kara,Thompson [38]
;
Vernon,Farewell [3]
作者单位：
Division of Rheumatology, Department of Medicine and Department of Pathology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada, john.hanly@cdha.nshealth.ca.
[1]
Department of Statistical Science, University College London, London.
[2]
MRC Biostatistics Unit, Institute of Public Health, University Forvie Site, Cambridge, UK.
[3]
Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada.
[4]
Instituto Nacional de Ciencias Medicas y Nutrición, Mexico City, Mexico.
[5]
Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
[6]
Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea.
[7]
Divisions of Rheumatology and Clinical Epidemiology, McGill University Health Centre.
[8]
Division of Rheumatology, University of Calgary, Alberta, Canada.
[9]
Cedars-Sinai/David Geffen School of Medicine at UCLA, Los Angeles, CA.
[10]
Department of Clinical Pharmacology, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
[11]
Centre for Rheumatology, Department of Medicine, University College London, UK.
[12]
Department of Medicine, SUNY Downstate Medical Center, Brooklyn, NY, USA.
[13]
Division of Rheumatology, Centre Hospitalier Universitaire de Québec et Université Laval, Quebec City, Canada.
[14]
Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
[15]
Arthritis Research UK Epidemiology Unit, Institute of Inflammation and Repair, Manchester Academic Health Sciences Centre, The University of Manchester, Manchester, UK, NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
[16]
Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, NC.
[17]
Northwestern University and Feinberg School of Medicine, Chicago, IL.
[18]
Feinstein Institute for Medical Research, Manhasset, NY.
[19]
Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
[20]
Center for Rheumatology Research, Landspitali University Hospital, Reykjavik, Iceland.
[21]
Department of Rheumatology, University Hospital Lund, Lund, Sweden.
[22]
Division of Rheumatology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
[23]
Lupus Research Unit, The Rayne Institute, St Thomas' Hospital, King's College London School of Medicine, London, UK.
[24]
Unit for Clinical Therapy Research, Karolinska Institute, Stockholm, Sweden.
[25]
Lanarkshire Centre for Rheumatology, Hairmyres Hospital, East Kilbride, Scotland, UK.
[26]
Josep Font Autoimmune Diseases Laboratory, IDIBAPS, Department of Autoimmune Diseases, Hospital Clínic, Barcelona, Spain.
[27]
Autoimmune Diseases Research Unit, Department of Internal Medicine, BioCruces Health Research Institute, Hospital Universitario Cruces, University of the Basque Country, Barakaldo, Spain.
[28]
Emory University School of Medicine, Division of Rheumatology, Atlanta, Georgia, USA.
[29]
Kantonsspital Geissbergstr, Schaffhausen, Switzerland.
[30]
Division of Rheumatology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey.
[31]
UCSD School of Medicine, La Jolla, CA.
[32]
Medical University of South Carolina, Charleston, SC, USA.
[33]
Ysbyty Gwynedd Bangor, Gwynedd, North Wales, UK.
[34]
University of Manitoba, Winnipeg, Manitoba, Canada.
[35]
Department of Rheumatology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
[36]
Hospital for Joint Diseases, NYU, Seligman Centre for Advanced Therapeutics, New York, NY, USA and.
[37]
Department of Medicine, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada.
[38]
主题词
成年人(Adult);疾病恶化(Disease Progression);女(雌)性(Female);随访研究(Follow-Up Studies);人类(Humans);发病率(Incidence);狼疮肾炎(Lupus Nephritis);男(雄)性(Male);前瞻性研究(Prospective Studies);生活质量(Quality of Life);危险因素(Risk Factors);存活率(Survival Rate)
DOI
10.1093/rheumatology/kev311
PMID
26342222
发布时间
2022-03-17
- 浏览63
Rheumatology (Oxford, England)
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
